Welcome to Sentinel Oncology
Sentinel Oncology Limited is committed to the discovery of new and innovate treatments for cancer patients. We are passionate about advancing novel ideas for new cancer drugs from concept to candidate drug selection....more
Our R&D is focused on the development of targeted therapeutics for areas of unmet medical need in oncology....more
Latest news & press releases
April 2014
Sentinel Oncology and Oncothyreon Collaborate to Develop and Commercialise Small Molecule Chk1 Inhibitors
Cambridge, UK, 22nd April 2014: Sentinel Oncology Ltd. (Sentinel), the small molecule drug discovery company, today announced… read more
May 2013
Sentinel Oncology achieves milestone in Horizon Discovery agreement
Cambridge, UK, 8th May 2013: Sentinel Oncology (Sentinel) today announced it has achieved a research milestone in its collaboration… read more
March 2013
Sentinel Oncology begin Discovery Collaboration with Professor Anthony Chalmers
Sentinel Oncology Limited (Sentinel) is pleased to announce the start of a collaboration with Professor Anthony Chalmers… read more